galantamine has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 9 (81.82) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
De Rosa, S; Iodice, C; Pejin, B; Tommonaro, G | 1 |
Arce, MP; Conde, S; del Barrio, L; Egea, J; García, AG; González-Muñoz, GC; León, R; López, B; López, MG; Martín-de-Saavedra, MD; Pérez, C; Rodríguez-Franco, MI; Romero, A; Villarroya, M | 1 |
Boonyarat, C; Reubroycharoen, P; Thiratmatrakul, S; Tohda, M; Vajragupta, O; Waiwut, P; Yenjai, C | 1 |
Ben Jannet, H; Ben Nejma, A; Daïch, A; Hamza, MA; Lawson, AM; Nguir, A; Othman, M | 1 |
Amooru, GD; Ampasala, DR; Darla, MM; Devineni, SR; Eadlapalli, S; Kotapati, KV; Palaka, BK; Penumala, M; Shaik, JB; Vadde, R | 1 |
Delogu, GL; Era, B; Fais, A; Fanti, M; Kumar, A; Matos, MJ; Medda, R; Pieroni, E; Pintus, F | 1 |
Horton, W; Kugyela, N; Kulkarni, A; LeVine, H; Peerannawar, S; Sood, A; Soule, J; Török, B; Török, M; Tran, CD; Tulsan, R | 1 |
Aktumsek, A; Alcaro, S; Bagetta, D; Carradori, S; De Monte, C; De Vita, D; Guglielmi, P; Ortuso, F; Petzer, A; Petzer, JP; Secci, D; Zengin, G | 1 |
Brazzolotto, X; Colletier, JP; Coquelle, N; Gobec, S; Jukič, M; Knez, D; Kos, J; Mravljak, J; Nachon, F; Pišlar, A; Sova, M; Žakelj, S | 1 |
Al-Hamashi, AA; Alhadidi, Q; Handunnetti, SM; Perera, L; Samaradivakara, SP; Samarasekera, R; Shah, ZA; Slama, JT; Taylor, WR; Tillekeratne, LMV; Weerasena, OVDSJ | 1 |
Amoroso, R; Carradori, S; De Filippis, B; Fantacuzzi, M | 1 |
1 review(s) available for galantamine and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
Article | Year |
---|---|
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy.
Topics: Humans; Neurodegenerative Diseases; Polyphenols; Resveratrol; Stilbenes; Structure-Activity Relationship | 2022 |
10 other study(ies) available for galantamine and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
Article | Year |
---|---|
Synthesis and biological activities of thio-avarol derivatives.
Topics: Animals; Anti-Infective Agents; Artemia; Cholinesterase Inhibitors; Dysidea; Free Radical Scavengers; Microbial Sensitivity Tests; Sesquiterpenes; Structure-Activity Relationship; Sulfur Compounds | 2008 |
N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antineoplastic Agents; Butyrylcholinesterase; Calcium; Cell Death; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Okadaic Acid; Peptide Fragments; Phenothiazines; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2011 |
Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Butyrylcholinesterase; Carbazoles; Cell Line; Cholinesterase Inhibitors; Electrophorus; Humans; Male; Memory Disorders; Mice; Molecular Docking Simulation; Oxidative Stress; Tacrine | 2014 |
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
Topics: Antioxidants; Atriplex; Cholinesterases; Ecdysterone; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Molecular Conformation; Plant Extracts; Plant Roots; Protein Binding | 2015 |
Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Binding Sites; Butyrylcholinesterase; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Computer Simulation; Coumarins; Drug Evaluation, Preclinical; Galantamine; Humans; Hydrogen Peroxide; Male; Mice, Inbred BALB C; Models, Molecular; Neuroprotective Agents; Neurotoxicity Syndromes | 2016 |
2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling.
Topics: Benzofurans; Butyrylcholinesterase; Cholinesterase Inhibitors; Models, Molecular | 2016 |
Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Carbolines; Cholinesterase Inhibitors; Cholinesterases; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2017 |
Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents.
Topics: Acetylcholinesterase; Animals; Antioxidants; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Electrophorus; Horses; Humans; Hydrazones; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Structure-Activity Relationship | 2018 |
Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Butyrylcholinesterase; Caco-2 Cells; Cell Line, Tumor; Cholinesterase Inhibitors; Drug Design; Humans; Ligands; Models, Molecular; Neuroprotective Agents; Piperidines | 2018 |
A Bioactive Resveratrol Trimer from the Stem Bark of the Sri Lankan Endemic Plant Vateria copallifera.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Dipterocarpaceae; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Molecular Structure; Neuroprotective Agents; PC12 Cells; Plant Bark; Rats; Resveratrol; Sri Lanka | 2018 |